Full text here: EASL | The Home of Hepatology To view or add a comment, sign in GLP-1 Receptor Agonists for Kidney Transplant Recipients Nephrology Dialysis Transplantation, 2025;, gfaf199, Published: 30 September 2025 Glucagon-like peptide-1 receptor agonists (GLP-1RA) are incretin-based therapies with demonstrated efficacy in glycemic control, weight reduction, and cardiovascular and renal protection
GLP-1 medications significantly reduce appetite and slow gastric emptying, which can impact nutrient intake during crucial growth periods
This deficiency, in turn, results in ROS accumulation, ultimately triggering ferroptosis [84, 85]
Our products are sold exclusively as pure compounds for research purposes and are not intended for use as dietary supplements
- L-arginina: 2 cpsulas (1 porcin) con alimentos, una vez al da